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Low aqueous solubility of API is a problem of drug product de-
velopment. There are several methods to enhance drug
solubility. Although drugs can increase solubility using many
chemical and physical modifications, the fewmethods are able
to enhance drug solubility for industrial scale [1]. Hot-melt ex-
trusion is one reliable process for enhancing drug solubility in
a large scale production. It has been recognized as a one step
process with several advantages. It can not only increase solu-
bility of drug, but can also be used as a process to prepare
controlled release dosage forms. Using a biodegradable polymer
with hot-melt extrusion, the drug release of up to 1–6 months
can be achieved [2].
Hot-melt extrusion can enhance drug solubility by stabi-
lizing drugs in amorphous form, deaggregating drug particles
in a carrier and improving wettability of drugs. A poorly
water-soluble drug and a hydrophilic polymer, such as
polyvinyl pyrrolidone, are selected and prepared to a solid dis-
persion using hot-melt extruder. The mixture is extruded to
a drug product. An increase in the drug solubility is
obtained [3].
One disadvantage of preparing solid dispersion by hot melt
extrusion is drug recrystallization. Drugs in amorphous form
and dissolved drugs can recrystallize upon storage. Some poly-
mers had the influence on drug recrystallization. Higher
molecular weight of the polymer showed the better inhibi-
tion of drug recrystallization. Moreover, the addition of some
additives and drug–polymer interaction could extend the drug
recrystallization. The inhibition of conversion from amor-
phous to crystalline drug was observed, thus more stable drug
in delivery systems [4].
Acknowledgments
The author acknowledges with thanks the support received
from Professor Dr. Isik Özgüney, Professor Dr. Roland Bodmeier
and German Academic Exchange Service (DAAD) for their
support and encouragement in carrying out this research and
work.
* E-mail address: duangrats@g.swu.ac.th.
Peer review under responsibility of Shenyang Pharmaceutical University.
http://dx.doi.org/10.1016/j.ajps.2015.10.032
1818-0876/© 2016 The Author. Production and hosting by Elsevier B.V. on behalf of Shenyang Pharmaceutical University. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
a s i an j o u rna l o f p h a rma c eu t i c a l s c i e n c e s 1 1 ( 2 0 1 6 ) 4 5 – 4 6
Available online at www.sciencedirect.com
journal homepage: www.elsevier.com/ locate /a jps
HOSTED BY
ScienceDirect
R E F E R E N C E S
[1] Kawabata Y, Wada K, Nakatani M, et al. Formulation design
for poorly water-soluble drugs based on biopharmaceutics
classification system: basic approaches and practical
applications. Int J Pharm 2011;420:1–10.
[2] Miller DA, McConville JT, Yang W, et al. Hot-melt extrusion for
enhanced delivery of drug particles. J Pharm Sci 2007;96:361–
376.
[3] Fousteris E, Tarantili PA, Karavas E, et al. Poly(vinyl
pyrrolidone)-poloxamer-188 solid dispersions prepared
by hot melt extrusion. J Therm Anal Calorim 2013;113:1037–
1047.
[4] Fule R, Amin P. Development and evaluation of lafutidine
solid dispersion via hot melt extrusion: investigating drug-
polymer miscibility with advanced characterization. Asian J
Pharm Sci 2014;9:92–106.
Fig. 1 – Schematic diagram of hot-melt extrusion process.
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